Julianne Messick, PharmD, Medical Writer: No relationships to disclose.

Brooks Cash, MD: Consultant: Salix, AbbVie, Ardelyx, AstraZeneca, Vibrant, Phathom, Speaker: Salix, AbbVie, QOL Medical, Ardelyx, Alnylam, AstraZeneca, Sanofi, Regeneron, Phathom

Christopher Chang, MD, PhD: No relationships to disclose.

Eric Shah, MD: Consultant: Ardelyx, Mahana, Sanofi, Salix, Takeda, Neuraxis, Mylan, GI Supply

Lucinda A. Harris, MS, MD: Consultant: AbbVie, Mahana, QOL Medical, Salix, Ardelyx, Gi Health Foundation, Advisor: Gemelli Biotech, Research: Takeda, Member: Rome Foundation

Kate Scarlata, MPH, RDN: Stock Options: Fody Foods, Epicured LLC, Advisor and Sponsorships: Mahana Therapeutics, Sponsorship for Events: Olipop, Nestle Health Science, Speaker/Sponsorship of Events: Dr. Schar, Pendulum Therapeutics, QOL Medical

Prashant Singh, MBBS: No relationships to disclose.

Joy Chang, MD, MS: Consultant: Sanofi/Regeneron

Gary W. Falk, MD, MS: Research Funding: Arena, Allakos, BMS/Celgene, Lucid, Sanofi/Regeneron, Takeda, Ellodi, Consultant: Nexstone, BMS/Celgene, Sanofi, Regeneron, Takeda, AstraZeneca, Ellodi, Upstream Bio

Jennifer Horsley-Silva, MD: Advisory Board: Sanofi, Regeneron, Disease State Panel: Regeneron

Carl Crawford, MD: Advisory Board: Ferring, Seres, Speaker: Ferring, Seres, Clinical Trial Site PI: Artugen

Teena Chopra, MD: Speaker: Ferring, Cepheid, Pfizer, Melinta, AbbVie, Consultant: Ferring, Cepheid, Pfizer

Paul Feuerstadt, MD: Speakers Bureau: Ferring, SERES, Takeda, Consultant: Ferring, SERES, Merck and Co., Takeda, Advisory Board: Ferring, SERES, Takeda, Regeneron

Stephen B. Hanauer, MD: Consultant: AbbVie, Allergan, Amgen, Arena, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Cosmos, Catalys Pacific, Covance, Genentech, GSK, Janssen, Lilly, Merck, Novartis, Pfizer, Progenity, Prometheus, Receptos, Salix, Samsung Bioepis, Seres Therapeutics, Sorriso, Takeda, TLL Pharma, UCB Pharma, VHsquared, DSMB: Arena, Boehringer Ingelheim, Bristol Myers Squibb, Gossamer, Prometheus, Protagonist, Speaker: AbbVie, Bristol Myers Squibb, Janssen, Pfizer, Takeda

Peter Higgins, MD: No relevant financial relationships to disclose.

Maria T. Abreu, MD: Consultant/Advisory Board: AbbVie Inc., Amgen, Arena, Bristol Myers Squibb, Celsius Therapeutics, Eli Lilly and Company, Gilead Sciences, Janssen, Microba Life Sciences, Pfizer, Prometheus, UCB Biopharma SRL, WebMD Glocal LLC, Speaker: Alimentiv, Amgen, Jassen, Takeda

Gary Lichtenstein, MD: Grants/Research Support: Celgene, Ferring, Janssen OrthoBiotech, Prometheus Laboratories, Inc., Salix, Santarus, Shire, UCB, Warner Chilcott, Consultant: AbbVie, Allergan, Alaven, American Gastroenterological Association, American Regent/Luitpold, Celgene, Eli Lilly (Consultant and DSMB), Endo Pharmaceuticals, Ferring, Gilead, Hospira, Janssen OrthoBiotech, Luitpold/American Regent, MedEd Consultants, Merick, Morphic Therapeutics, Pfizer Pharmaceuticals, Prometheus Laboratories, Inc., Romark, Sandoz, Salix Pharmaceuticals/Valeant, Santarus/Receptos, Shire, Takeda, UCB, Virgo (stock option), Honorarium Recipient: Chemed (CME), IMEDEX (CME), Ironwood (CME), Luitpold/American Regent (CME Programs), Merck (CME Program), Romark (CME), University of Kentucky (CME), Vindico (CME), Editorial Board Involvement: Gastroenterology and Hepatology (Gastro-Hep Communications) – Executive Editor, American College of Gastroenterology (Associate Editor – American Journal of Gastroenterology), Other Financial Material Support: SLACK, Inc. (book royalty), Janssen OrthoBiotech (IBD Fellowship Funding), McMahon Publishing – Author (Honorarium), Professional Communications, Inc. (textbook editor honorarium), Takeda (grant), Up To Date (author), Springer Science and Medica (Editor honorarium), Takeda (IBD Fellowship Funding)